9780470195109-047019510X-Drugs: From Discovery to Approval

Drugs: From Discovery to Approval

ISBN-13: 9780470195109
ISBN-10: 047019510X
Edition: 2
Author: Rick Ng
Publication date: 2008
Publisher: Blackwell Pub
Format: Hardcover 442 pages
FREE US shipping

Book details

ISBN-13: 9780470195109
ISBN-10: 047019510X
Edition: 2
Author: Rick Ng
Publication date: 2008
Publisher: Blackwell Pub
Format: Hardcover 442 pages

Summary

Drugs: From Discovery to Approval (ISBN-13: 9780470195109 and ISBN-10: 047019510X), written by authors Rick Ng, was published by Blackwell Pub in 2008. With an overall rating of 3.6 stars, it's a notable title among other Industrial & Technical (Chemistry, Pharmacy, Pharmacology) books. You can easily purchase or rent Drugs: From Discovery to Approval (Hardcover) from BooksRun, along with many other new and used Industrial & Technical books and textbooks. And, if you're looking to sell your copy, our current buyback offer is $0.4.

Description

"Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs."
Doody's Reviews, May 2009

"The second edition of a book that offers a user-friendly step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of preclinical trials."
Chemistry World, February 2009

The new edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, the book quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs.

This second edition features many key enhancements, including Key Points, Chapter Summary, and Review Questions in each chapter, Answers to Review Questions provided in a book-end appendix, and one or two carefully selected "mini" case studies in each chapter.

Richly illustrated throughout with over ninety figures and tables, this important book also includes helpful listings of current FDA and European guidelines and a special section on regulatory authority and processes in China. It is an indispensable resource for pharmaceutical industry and academic researchers, pharmaceutical managers and executives, healthcare clinicians, policymakers, regulators, and lobbyists with an interest in drug development. It is also an excellent textbook for students in pharmacy, science, and medicine courses.

Rate this book Rate this book

We would LOVE it if you could help us and other readers by reviewing the book